Fibromyalgia Therapeutics - Pipeline Analysis 2018

Fibromyalgia therapeutic pipeline is expected to experience a positive trend in the coming years. Prevalence of fibromyalgia is increasing due to very large number of patients suffering from lifestyle disease, psychological stress, trauma, tension, headaches, anxiety and depression. Some of the significant factors driving the pipeline for fibromyalgia include rising prevalence of fibromyalgia and the increasing health awareness among the population, globally. According to the National Fibromyalgia and Chronic Pain Association, around 10 million Americans are suffering from fibromyalgia in the U.S. Also, nearly 2% to 4% of world’s population was affected with fibromyalgia in 2015. It is more prevalent in women than in men. The risk factors of developing fibromyalgia include family history and other disorders such as osteoarthritis, rheumatoid arthritis or lupus.

Explore Report Sample at: https://www.psmarketresearch.com/market-analysis/fibromyalgia-therapeutics-pipeline-analysis/report-sample

Fibromyalgia is a disease that affects muscles and soft tissues in the body. It is believed that fibromyalgia amplifies painful sensations by affecting the way brain processes signals. Symptoms of fibromyalgia include fatigue, excessive pain and cognitive difficulties. Fibromyalgia is usually associated with other diseases including irritable bowel syndrome, migraine, interstitial cystitis, temporomandibular joint disorders, anxiety and depression. The causes of fibromyalgia can be physical or emotional trauma, genetic factors and infections. The complications that occur due to having fibromyalgia include pain and lack of sleep that can interfere with the ability to function at home or at work. Fibromyalgia can be easily diagnosed by blood tests that include complete blood count, erythrocyte sedimentation rate, cyclic citrullinated peptide test, rheumatoid factor and thyroid function tests. The treatment of fibromyalgia include self-care and medications. Medications for relieving the symptoms of fibromyalgia include pain relievers such as acetaminophen, ibuprofen or naproxen sodium, antidepressants namely; duloxetine and milnacipran and anti-seizure drugs namely; gabapentin and pregabalin. The therapies which can improve fibromyalgia condition include physical therapy, occupational therapy and counselling. Physical therapy helps in improving strength, flexibility and stamina while occupational therapy helps to make adjustments in work area. There are other alternative treatments that are also present for treating fibromyalgia, such as, acupuncture, massage therapy and yoga.

Explore Report at: https://www.psmarketresearch.com/market-analysis/fibromyalgia-therapeutics-pipeline-analysis

Some of the companies having a pipeline of fibromyalgia therapeutics include Intellipharmaceutics International, Inc., Daiichi Sankyo Company Ltd., KPI Therapeutics, Inc., Merck & Co. Inc., Theravance Biopharma Inc., Pfizer Inc., Astellas Pharma, Inc., Immune Therapeutics, Inc., Zynerba Pharmaceuticals, Inc., Vitality Biopharma, Inc.

About P&S Market Research

P&S Market Research is a market research company, which offers market research and consulting services for various geographies around the globe. We provide market research reports, industry forecasting reports, business intelligence, and research based consulting services across different industry/business verticals.

As one of the top growing market research agency, we’re keen upon providing market landscape and accurate forecasting. Our analysts and consultants are proficient with business intelligence and market analysis, through their interaction with leading companies of the concerned domain. We help our clients with B2B market research and assist them in identifying various windows of opportunity, and framing informed and customized business expansion strategies in different regions.

Contact:
P&S Market Research
347, 5th Ave. #1402
New York City, NY - 10016
Toll-Free: +1-888-778-7886 (USA/Canada)
Email: enquiry@psmarketresearch.com
Web: https://www.psmarketresearch.com

This release was published on openPR.